The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA

Article usage
Posted July 14, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (280)
- Allergy and Immunology (579)
- Anesthesia (139)
- Cardiovascular Medicine (1944)
- Dermatology (184)
- Emergency Medicine (333)
- Epidemiology (11100)
- Gastroenterology (623)
- Genetic and Genomic Medicine (3164)
- Geriatric Medicine (308)
- Health Economics (561)
- Health Informatics (2042)
- Health Policy (863)
- Hematology (310)
- HIV/AIDS (682)
- Medical Education (317)
- Medical Ethics (92)
- Nephrology (334)
- Neurology (2985)
- Nursing (164)
- Nutrition (463)
- Oncology (1550)
- Ophthalmology (477)
- Orthopedics (185)
- Otolaryngology (266)
- Pain Medicine (202)
- Palliative Medicine (57)
- Pathology (402)
- Pediatrics (912)
- Primary Care Research (355)
- Public and Global Health (5590)
- Radiology and Imaging (1093)
- Respiratory Medicine (759)
- Rheumatology (338)
- Sports Medicine (289)
- Surgery (343)
- Toxicology (48)
- Transplantation (159)
- Urology (132)